Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000893220-06-000625
Filing Date
2006-03-20
Accepted
2006-03-20 17:21:49
Documents
5
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K VALERA PHARMACEUTICALS w17428e10vk.htm 10-K 1007288
2 CORPORATE CODE OF BUSINESS CONDUCT AND ETHICS w17428exv14w1.htm EX-14.1 37021
3 CERTIFICATION OF CEO w17428exv31w1.htm EX-31.1 5549
4 CERTIFICATION OF CFO w17428exv31w2.htm EX-31.2 5539
5 CERTIFICATION OF CEO AND CFO w17428exv32.htm EX-32 1735
  Complete submission text file 0000893220-06-000625.txt   1058472
Mailing Address 8 CLARKE DR CRANBURY NJ 08512
Business Address 8 CLARKE DR CRANBURY NJ 08512 609-409-9010
Valera Pharmaceuticals Inc (Filer) CIK: 0001305409 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51768 | Film No.: 06699412
SIC: 2834 Pharmaceutical Preparations